Amid an exchange of mutual accusations about who was responsible for starting the coronavirus pandemic, both China and the US are frantically seeking the ultimate weapon to stop it – a vaccine for the novel virus. But who is leading this pharmaceutical race and what happens when such a vaccine is found? It’s hard to predict which of the two states will come up with a vaccine first, as the two are investing heavily in the effort and for both it’s a matter of “national pride” and hence a priority, Gerald Posner, a bestselling author and investigative journalist, says. He adds that despite the two countries working on several vaccine variants, none of these is guaranteed of success. “Historically, just about 6% of vaccine candidates end up making it to the market. So, it’s a very difficult process. Things that look good in the lab, when they start human testing, can change dramatically”, Posner said. The two countries certainly have different competitive advantages, Rachna Shah, a professor in the Supply Chain and Operations Department at the Carlson School of Management at the University of Minnesota, notes. Namely, China is responsible for a major part of the global production of Active… Read full this story
- Modi-Xi Wuhan Summit: Critical analysis of competition and cooperation
- If India and China can’t cooperate in Nepal, why do they aspire to do it a more complex Afghanistan?
- Penalties against China telecom giant ZTE become a bargaining chip as White House, Chinese officials discuss potential trade deal
- China lauds Pak role against terrorism
- White House moves ahead with tough trade measures on China
- Namibia, China sign inter-parliamentary accord
- China rages over US warships sailing near disputed islands, saying move 'seriously infringed' its sovereignty
- Japan looks to team up with island nations on Indo-Pacific strategy
- UN, OIC resolutions must be main message to all Muslim countries that want to develop relations with Armenia – Azerbaijani FM
- Africa: China's Strategy in Africa
- Should Vaccines be Mandatory for Children in the US?
- Ethiopia: Empowering Women for Socio-Economic Development
- Congo-Kinshasa: As Congo Faces First Urban Ebola Outbreak, Experimental Vaccine Deployed
- Outflanked by China, Tillerson arrives in Africa with a narrow mission — counter-terrorism
- Sanctions against China telecom giant ZTE become a bargaining chip in potential U.S.-China trade deal
- China’s long march for the soul of the nation’s digital future
- Home/ China-USFM: Better ties sought with US
- China: Sino-Africa links purely mutual
- China sentences Xi Jinping's former rival to life in prison
- China wants premier's Japan trip to return ties to normal
Matter of National Pride: Why US and China Don't Cooperate on Developing COVID-19 Vaccine have 408 words, post on sputniknews.com at April 30, 2020. This is cached page on The Best Articles. If you want remove this page, please contact us.